期刊文献+

IFNγ在动脉粥样硬化形成中的作用 被引量:4

Roles of IFNγ in the atherogenesis
下载PDF
导出
摘要 干扰素γ(IFNγ)又称免疫干扰素,其抗病毒活性较低,免疫调节和抗细胞增殖作用较强,是一种强的巨噬细胞、NK细胞、血管内皮细胞活化剂。IFNγ增强抗原提呈,活化T淋巴细胞,与多种致炎因子相互作用,促进粥样病变处炎症反应,加重病变进展。作为脂质代谢相关酶的调节因子,IFNγ诱导泡沫细胞形成,并活化内皮细胞促进动脉粥样硬化。但也有研究显示,它可影响一些脂质受体抑制泡沫细胞形成,并减少平滑肌细胞增殖而对动脉粥样硬化形成起保护作用。 Interferonγ (IFNγ) , also called immune interferon, has low activity against virus, but it plays strong role in immunological regulation and in inhibition of cell proliferation. It is a strong activator for macrophages, NK cells and vascular endothelial cells. It can promote the inflammation of the atherosclerosis lesions through enhancing antigen-presentation, activating T lymphocytes and interacting with many kinds of cytokines. As a mediator of enzymes related to lipid metabolism, IFNγ can induce the formation of foam cells as well as activate endothelial cells, and thus accelerate atherogenesis. However, there is also evidence that IFNγ can inhibit the formation of foam cells by affecting lipid receptors and decreasing vascular smooth cells proliferation, suggestting that IFNγ may also has an anti-antherosclerosis effect.
作者 夏妍 杨永宗
出处 《国际病理科学与临床杂志》 CAS 2008年第2期118-121,共4页 Journal of International Pathology and Clinical Medicine
关键词 干扰素Γ 动脉粥样硬化 炎症反应 泡沫细胞 interferonγ atherosclerosis inflammation foam cell
  • 相关文献

参考文献25

  • 1Pfeilschifter MH. Anti-inflammatory properties of pro-inflammatory interferon-gamma[ J ]. Int hnmunopharmacol, 2003,3 ( 9 ) : 1247- 1255.
  • 2Schoenborn JR, Wilson CB. Regulation of interferon-gamma during innate and adaptive immune responses[ J]. Adv hnmunol, 2007, 96:41-101.
  • 3Romero FI,Khamashta MA, Hughes GR. Lipoprotein(α) oxidation and autoantibodies: a new path in atherothrombosis [ J ]. Lupus, 2000,9 ( 3 ) : 206-209.
  • 4Whitman SC, Ravisankar P, Daugherty A. IFN-gamma deficiency exerts gender-specific effects on atherogenesis in apolipoprotein E^-/- mice[J]. J Interferon Cytokine Res,2002,22(6) :661-670.
  • 5Munder M, Mallo M, Eichmann K, et al. Murine macrophages secrete interferon gamma upon combined stimulation with interleukin (IL) -12 and IL-18 : A novel pathway of autocrine macrophage activation[J], Exp Med, 1998, 187 (12) :2103-2108.
  • 6Fukao T, Frucht DM, Yap G, et al. Inducible expression of Star4 in dendritic cells and macrophages and its critical role in innate and adaptive immune responses [ J ]. J Immunol, 2001, 166 ( 7 ) :4446- 4455.
  • 7Wuttge DM, Zhou X, Sheikine Y, et al. CXCL16/SR-PSOX is an interferon-gamma-regulated chemokine and scavenger receptor ex- pressed in atherosclerotic lesions[ J ]. Arterioscler Thromb Vasc Biol, 2004,24(4) :750-755.
  • 8柯丽,成蓓,余其振,何平,白智峰.干扰素-γ对单核—巨噬细胞源性泡沫细胞ACAT-1表达的影响[J].山东医药,2005,45(10):14-15. 被引量:8
  • 9Wang XQ, Panousis CG, Alfaro ML,et al. Interferon-gamma-mediated downregulation of cholesterol efflux and ABC1 expression is by the Statl pathway[ J]. Arterioscler Thromb Vasc Biol,2002,22 (5) :e5-9.
  • 10Tengku-Muhammad TS, Hughes TR, Cryer A,et al. Synergism between lipopolysaccharide and interferon gamma in the regulation of lipoprotein lipase in macrophages [ J ]. Cytokine, 1999,11 (6) : 408-415.

二级参考文献15

  • 1Miyazaki A,Sakai M,Sakamoto Y,et al.Acyl-coenzyme A:cholesterol acyltransferase inhibitors for controlling hyperchol-esterolemia and atherosclerosis.Curr Opin Investig Drugs,2003,4(9): 1095~1099.
  • 2Chung HK,Lee IK,Kang H,et al.Statin inhibits interferon-gamma-induced expression of intercellular adhesion molecule-1 (ICAM-1) in vascular endothelial and smooth muscle cells.Exp Mol Med,2002,34(6):451~461.
  • 3Libby P,Ridker PM,Maseri A.Inflammation and athero-sclerosis.Circulation,2002,105(9): 1135~1143.
  • 4Batetta B,Mulas MF,Petmzzo P,et al.Opposite pattern of MDR1 and caveolin-1 gene expression in human atherosclerotic lesions and proliferating human smooth muscle cells.Cell Mol Life Sci,2001,58(8):1113~1120.
  • 5Petruzzo P,Cappai A,Brotzu G,et al.Lipid metabolism and molecular changes in normal and atherosclerotic Vessels.Eur J Vase Surg,2001,22(1 ): 31~36.
  • 6Acton S, Scherer P, Lodish H, et al. Expression cloning of SR-BI, a CD36-related class B scavenger receptor. J Biol Chem, 1994, 269(31): 21003-20019.
  • 7Landschulz KT, Pathak RK, Rigotti A, et al. Regulation of scavenger receptor, class B, type I, a high density lipoprotein receptor, in liver and steroidogenic tissues of the rat. J Clin Invest,1996, 98(4): 984-995.
  • 8Hirano K, Yamashita S, Nakagawa Y,et al. Expression of human scavenger receptor class B type I in cultured human monocyte-derived macrophages and atherosclerotic lesions. Circ Res, 1999, 85(1):108 -116.
  • 9Murao K, Terpstra V, Green SR,et al. Characterization of CLA-1, a human homologue of rodent scavenger receptor BI, as a receptor for high density lipoprotein and apoptotic thymocytes. J Biol Chem, 1997 ,272 (28):17551-17557.
  • 10Arai T, Wang N, Bezouevski M,et al. Decreased atherosclerosis inheterozygous low density lipoprotein receptor-deficient mice expressing the scavenger receptor BItransgene. J Biol Chem, 1999, 274(4):2366-2371.

共引文献8

同被引文献70

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部